CooperCompanies Delivers Strong Financial Performance
SAN RAMON, Calif. -- CooperCompanies (Nasdaq: COO), a prominent leader in the medical device sector, proudly announced its financial results for the fiscal fourth quarter, concluding a successful year ending October 31, 2025. With significant growth demonstrated, the company is setting a sturdy foundation for future achievements.
Fourth Quarter Highlights
In the fourth quarter of 2025, CooperCompanies posted a remarkable revenue of $1,065.2 million, reflecting a 5% increase compared to the previous year. Adjusting for constant currency impacts, the organic growth stood at 3%, illustrating the resilience of their products amidst market fluctuations. The total revenue for fiscal year 2025 reached an impressive $4.1 billion, marking a similar 5% growth. This performance showcases the company's ability to navigate challenges effectively while staying focused on its strategic objectives.
Earnings Overview
For the fourth quarter, the GAAP diluted earnings per share (EPS) was recorded at $0.43, facing a slight decline of 27%. However, on the non-GAAP front, the diluted EPS increased to $1.15, up 11% from the previous quarter, indicating stronger operational results when excluding one-time charges. Overall, the fiscal year 2025 saw a GAAP diluted EPS of $1.87, down 4%, while the non-GAAP figure improved to $4.13, demonstrating a 12% growth.
Operational Excursions
CooperVision, one of the two main divisions of CooperCompanies, showed remarkable progress. Their innovative MyDay product secured numerous contract victories, while sales from MiSight increased by 37% in Q4. CooperSurgical also concluded the year with commendable results, achieving revenue figures at the upper limits of their guidance, particularly in their fertility segment.
Strategic Initiatives for Growth
"Entering 2026, we are committed to accelerating top-line growth, enhancing profitability, and optimizing cash generation while maintaining our stock buyback program," stated Al White, President and CEO. This strategic roadmap is anticipated to secure the company’s long-term value creation for its shareholders, with expectations of generating over $2.2 billion in free cash flow across the next three years.
Financial Metrics and Margins
In Q4, the company experienced a gross margin of 61%, down from 67% a year earlier, largely attributable to ongoing reorganization efforts. Non-GAAP gross margin was calculated at 66%, reflecting a focus on operational efficiency. The operating margin, on a GAAP basis, dropped to 13% compared to 19% last year but improved to 27% on a non-GAAP basis, indicating effective leverage of operational expenses despite the challenges faced.
Cash Flow and Share Repurchase Initiatives
The operational cash flow for this quarter amounted to $247.8 million, with capital expenditures at $98.0 million, resulting in $149.8 million of free cash flow. The company has been active in repurchasing shares, totaling $197.3 million during the quarter and $290.1 million for the entirety of 2025. Ongoing efforts to enhance operational structure are expected to yield pre-tax savings, further consolidating its market position.
Looking Ahead: Fiscal Year 2026 Guidance
CooperCompanies has outlined an optimistic financial guidance for the upcoming fiscal year. Projected total revenue for the first quarter is between $1,019 and $1,030 million, paired with an anticipated non-GAAP diluted EPS between $1.02 and $1.04. The broader fiscal year 2026 revenue is pegged at $4.299 to $4.338 billion, emphasizing a sustained organic growth rate of around 4.5% to 5.5%.
Frequently Asked Questions
What were CooperCompanies' total revenues for the fourth quarter?
The total revenues for the fourth quarter were reported at $1,065.2 million.
How did CooperCompanies' earnings per share perform in Q4 2025?
The GAAP diluted earnings per share were $0.43, while the non-GAAP diluted EPS was $1.15.
What growth strategies is CooperCompanies focusing on going into 2026?
The company is emphasizing accelerating top-line growth, enhancing profitability, and optimizing cash generation while continuing share repurchases.
What is the expected free cash flow outlook for CooperCompanies?
The company anticipates generating more than $2.2 billion in free cash flow from 2026 through 2028.
How did CooperVision perform in the fourth quarter?
CooperVision reported a revenue of $709.6 million, showing a growth of 5% from the same period last year, with significant contributions from the MyDay product line.
